Furthermore, it is highly possible that targeting KDR would provide effective anti‐cancer therapy for squamous thyroid cancer, ultimately improving the disease survival rate of advanced thyroid cancer patients in the clinic. The gene discussed is KDR; the disease is thyroid cancer.